Key publications on TRIPS and the life sciences
General publications
Articles & book chapters
- Helfer, Laurence R. "Regime shifting: the TRIPs agreement and new dynamics of international intellectual property lawmaking." Yale J. Int'l L. 29 (2004): 1.
- Park, Walter G., and Douglas Lippoldt. "International licensing and the strengthening of intellectual property rights in developing countries during the 1990s." OECD Economic Studies 2005.1 (2005): 7-48.
- Thomas, Kristie. "The TRIPS Agreement: Developing Global Rules for Intellectual Property Protection."Assessing Intellectual Property Compliance in Contemporary China. Springer Singapore, 2017. 43-66.
- Worthy, John. "Intellectual property protection after GATT." European Intellectual Property Review 16 (1994) (available from Westlaw)
Books
- Frankel, Susy, and Gervais, Daniel J., Advanced introduction to international intellectual property. Edward Elgar, 2016
- Ruse-Khan, Henning Grosse, The Protection of Intellectual Property in International Law. Oxford University Press, 2016.
TRIPS and the life sciences
- Abbott, Frederick M., and Jerome H. Reichman. "The Doha Round's public health legacy: Strategies for the production and diffusion of patented medicines under the amended TRIPS provisions." Journal of international economic law 10.4 (2007): 921-987.
- Correa, Carlos M., UNDP guidelines for the examination of patent applications relating to pharmaceuticals, UNDP 2016
- DESAI, Manisha. Compulsory licensing: Procedural requirements under the TRIPS Agreements. Pharmaceuticals Policy and Law (2016) 18: 31–44. DOI 10.3233/PPL-160430
- Holman, Christopher M. In defence of secondary pharmaceutical patents: A response to the UN's guidelines for pharmaceutical patent examination. Indiana Law Review (2017) 50 (3): 759– 811.?
- Reichman, Jerome H., Paul F. Uhlir, and Tom Dedeurwaerdere. Governing digitally integrated genetic resources, data, and literature: Global intellectual property strategies for a redesigned microbial research commons. Cambridge University Press, 2016.
- SNODIN, Mike. Pharmaceutical innovations and obligations under TRIPS. Journal of Intellectual Property Law & Practice (2017) 12 (6): 489–501.
- SOLOVY, Eric M, KRISHNAMURTHY, Pavan S. TRIPS Agreement flexibilities and their limitations: A response to the UN Secretary General’s High-Level Panel Report on Access to Medicines. ?George Washington International Law Review, Vol. 50, No. 1, 2017.
- UN secretary-general’s High-level Panel on access to medicines Report, Promoting innovation and access to health technologies, September 2016